SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
PhaseBio Pharmaceuticals, Inc. Received an Additional $23 Million With Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio